Central nervous system vasculitis after starting methimazole in a woman with Graves' disease

Thyroid

Volumn 18, Issue 9, 2008, Pages 1011-1013

  Tripodi, Pier Francesco ^a   Ruggeri, Rosaria M ^a   Campennì, Alfredo ^a   Cucinotta, Mariapaola ^a   Mirto, Angela ^a   Lo Gullo, Renato ^a   Baldari, Sergio ^a   Trimarchi, Francesco ^a   Cucinotta, Domenico ^a   Russo, Giuseppina T ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CARBAMAZEPINE; FUROSEMIDE; RANITIDINE; TECHNETIUM 99M; THIAMAZOLE;

ACHILLES REFLEX; ADULT; BLOOD FLOW; CASE REPORT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULITIS; VITAL SIGN;

ADULT; ANTITHYROID AGENTS; BRAIN; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; METHIMAZOLE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 51849137955     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0121     Document Type: Conference Paper

References (19)

1. Laurberg P, Andersen S, Karmisholt J 2006 Antithyroid drug therapy of Graves' hyperthyroidism: realistic goals and focus on evidence. Exp Rev Endocrinol Metab 1:91-102.
2. Cooper DS 2005 Antithyroid drugs. N Engl J Med 3:905-917.
3. Kitahara T, Hiromura K, Maezawa A, Ono K, Narabara N, Yano S, Naruse T, Takenouchi K, Yasumoto Y 1997 Case of propylthiouracil induced vasculitis associated with antineutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol 47:336-340.
4. Gunton JE, Stiel J, Caterson RJ, McElduff A 1999 Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 84:13-16.
5. Chen YX, Yu HJ, Ni LY, Zhang W, Xu YW, Ren H, Chen XN, Wang XL, Li X, Pan XX, Wang WM, Chen N 2007 Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 34:2451-2456.
6. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A 2000 Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 57:846-862.
7. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K 2000 Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 10:595-599.
8. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N 2002 Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr J 49:329-334.
9. Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA 2004 Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol 60:671-675.
10. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M 2005 Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitis. Arthritis Res Ther 7:1072-1081.
11. Batchelor N, Holley A 2006 A fatal case of propylthiouracil-induced ANCA-positive vasculitis. Med Gen Med 8:10.
12. Vanek C, Samuels MH 2005 Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review. Thyroid 15:80-84.
13. ten Holder SM, Joy MS, Falk RJ 2002 Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 36:130-147.
14. Kawaki Y, Nukaga H, Hoshito M, Iwata M, Otsuka F 1995 ANCA associated vasculitis and lupus like syndrome caused by methimazole. Clin Exp Dermatol 20:345-347.
15. Tsai MH, Chang YL, Wu VC, Chang CC, Huang TS 2001 Methimazole-induced pulmonary hemorrhage associated with antimyeloperoxidase-antineutrophil cytoplasmic antibody: a case report. J Formos Med Assoc 100:772-775.
16. Thong HY, Chu CY, Chiu HC 2002 Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta Derm Venereol 82:206-208.
17. Masor JJ, Gal AA, LiVolsi VA 1994 Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis. Am J Med Sci 308:112-114.
18. Raillard-Gohin H, Leray-Moragues H, Canaud B, Pages M 2001 Systemic vasculitis and hyperthyroidism in a patient with myasthenia gravis. J Neurol 248:525-526.
19. Tomer Y 2001 Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11:167-169.